Try our Advanced Search for more refined results
Ferring Pharmaceuticals
-
Order | Filed: May 13, 2024 | Entered: May 13, 2024 Ferring Pharmaceuticals Inc. et al v. Finch Therapeutics Group, Inc. et al
Patent | Delaware
SO ORDERED ~Util - Set Hearings Order Setting Briefing Schedule - open, ans, reply, surreply
SO ORDERED, re 333 MOTION for Teleconference to Resolve Discovery Disputes A Discovery Dispute Motion Hearing is set for May 23, 2024 at 3:00 PM before Judge Sherry R. Fallon. In preparation for this hearing the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Order regarding discovery matters available at www.ded.uscourts.gov/judge/magistrate-judge-sherry-r-fallon. Plaintiff should obtain court reporting services for the conference, with the cost to be shared equally between both sides. No later than May 22, 2024 at 3:00 PM, the parties shall send a joint email to Larisha_Hicks@ded.uscourts.gov containing (i) the name of the court reporter; (ii) the name of the court reporting agency; and (iii) confirmation that the court reporter has been provided with the courts AT&T dial-in information. The Court may choose to resolve the disputes prior to the telephone conference and will, in that event, cancel the conference. Set Deadlines: (Moving Submission due by no later than 5/15/2024 at 11:00 AM, Responsive Submission due by no later than 5/16/2024 at 11:00 AM.). Signed by Judge Sherry R. Fallon on 5/13/2024. (Polito, Rebecca)
-
Order | Filed: May 13, 2024 | Entered: May 13, 2024 Ferring Pharmaceuticals Inc. et al v. Finch Therapeutics Group, Inc. et al
Patent | Delaware
Order Referring Motion
ORAL ORDER REFERRING MOTION: IT IS HEREBY ORDERED that the Motion for Teleconference to Resolve Discovery Disputes (D.I. 333 ) is now REFERRED to Magistrate Judge Sherry R. Fallon. Ordered by Judge Jennifer L. Hall on 5/13/2024. (ceg)
-
Misc | Filed: May 13, 2024 | Entered: May 13, 2024 Ferring Pharmaceuticals Inc. et al v. Finch Therapeutics Group, Inc. et al
Patent | Delaware
Request for Oral Argument
REQUEST for Oral Argument by Ferring Pharmaceuticals Inc., Rebiotix Inc. re 316 MOTION for Leave to File First Amended Reply and Counterclaims in Reply. (Bourke, Mary)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login